Cloning of a navel scavenger receptor cysteine-rich type I transmembrane molecule (M160) expressed by human macrophages

被引:45
作者
Gronlund, J [1 ]
Vitved, L [1 ]
Lausen, M [1 ]
Skjodt, K [1 ]
Holmskov, U [1 ]
机构
[1] Univ So Denmark, Med Biol Inst, Dept Immunol & Microbiol, Odense, Denmark
关键词
D O I
10.4049/jimmunol.165.11.6406
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report the cloning of a novel human type I cell surface Ag mainly expressed by macrophages. The primary structure was established by molecular cloning, which yielded a 4579-bp cDNA sequence encoding a polypeptide chain of 1453 amino acid residues with 16 potential N-glycosylation sites. We designated this molecule M160, The domain organization features 12 scavenger receptor cysteine-rich domains followed by a, transmembrane region and a cytoplasmic domain that occurs in two forms, a predominant form (M160-alpha) of 71 residues and an alternatively spliced form (M160-beta) of 39 residues. M160-alpha contains three possible phosphorylation sites, which are lost in the alternatively spliced form, RT-PCR analyses showed M160 to be expressed by alveolar macrophages and by the monocyte cell lines HL60, U937, and THP1, but not by Jurkat or Raji cells. Stimulation of U937 cells with phorbol ester resulted in an increased expression of M160 from day 5 onward. RT-PCR analysis of 19 different human tissues showed signals for M160-alpha of varying intensity in all tissues, whereas M160-beta was confined to the spleen. We conclude that M160 is a new member of the scavenger receptor cysteine-rich superfamily expressed by the monocyte/macrophage cell lineage.
引用
收藏
页码:6406 / 6415
页数:10
相关论文
共 44 条
[1]  
[Anonymous], [No title captured]
[2]   THE LYMPHOCYTE GLYCOPROTEIN-CD6 CONTAINS A REPEATED DOMAIN-STRUCTURE CHARACTERISTIC OF A NEW FAMILY OF CELL-SURFACE AND SECRETED PROTEINS [J].
ARUFFO, A ;
MELNICK, MB ;
LINSLEY, PS ;
SEED, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (04) :949-952
[3]   Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes [J].
Biancone, L ;
Bowen, MA ;
Lim, A ;
Aruffo, A ;
Andres, G ;
Stamenkovic, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :811-819
[4]   A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5 [J].
Bikah, G ;
Lynd, FM ;
Aruffo, AA ;
Ledbetter, JA ;
Bondada, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (08) :1185-1196
[5]   The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry [J].
Bowen, MA ;
Bajorath, J ;
Siadak, AW ;
Modrell, B ;
Malacko, AR ;
Marquardt, H ;
Nadler, SG ;
Aruffo, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (29) :17390-17396
[6]   CLONING, MAPPING, AND CHARACTERIZATION OF ACTIVATED LEUKOCYTE-CELL ADHESION MOLECULE (ALCAM), A CD6 LIGAND [J].
BOWEN, MA ;
PATEL, DD ;
LI, X ;
MODRELL, B ;
MALACKO, AR ;
WANG, WC ;
MARQUARDT, H ;
NEUBAUER, M ;
PESANDO, JM ;
FRANCKE, U ;
HAYNES, BF ;
ARUFFO, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2213-2220
[7]   CD5 ACTS AS A TYROSINE KINASE SUBSTRATE WITHIN A RECEPTOR COMPLEX COMPRISING T-CELL RECEPTOR ZETA-CHAIN CD3 AND PROTEIN-TYROSINE KINASES P56LCK AND P59FYN [J].
BURGESS, KE ;
YAMAMOTO, M ;
PRASAD, KVS ;
RUDD, CE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9311-9315
[8]  
Calvo J, 1999, EUR J IMMUNOL, V29, P2119, DOI 10.1002/(SICI)1521-4141(199907)29:07<2119::AID-IMMU2119>3.0.CO
[9]  
2-F
[10]  
Cheng H, 1996, ANAT REC, V244, P327